Cliff Morgan
Overview
Explore the profile of Cliff Morgan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
827
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papiris S, Campo I, Mariani F, Kallieri M, Kolilekas L, Papaioannou A, et al.
ERJ Open Res
. 2023 Jan;
9(1).
PMID: 36601310
https://bit.ly/3M0wKnZ.
2.
Lund-Palau H, Juarez-Molina C, Meng C, Bhargava A, Pilou A, Aziz K, et al.
Mol Ther Methods Clin Dev
. 2022 May;
25:382-391.
PMID: 35573048
We developed a novel lentiviral vector, pseudotyped with the F and HN proteins from Sendai virus (rSIV.F/HN), that produces long-lasting, high-efficiency transduction of the respiratory epithelium. Here we addressed whether...
3.
Schmidt A, Kenia P, Morgan C, Bush A
Pediatr Pulmonol
. 2021 Feb;
56(6):1687-1689.
PMID: 33629535
A girl with a known chromosomal deletion at Xp22.33, learning difficulties and short stature presented with dyspnea and dry cough and an abnormal chest X-ray. Computed tomography was typical for...
4.
Smith A, Morgan C, Ledot S, Doyle J, Xu T, Shedden L, et al.
Acta Cardiol
. 2021 Jan;
76(5):455-458.
PMID: 33390090
Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO) provides a bridge to recovery in patients with acute respiratory failure due to the acute respiratory distress syndrome (ARDS). Survival in ARDS has improved over...
5.
Igra A, McGuire H, Naldrett I, Cervera-Jackson R, Lewis R, Morgan C, et al.
Future Healthc J
. 2020 Oct;
7(3):181-184.
PMID: 33094219
The COVID-19 pandemic brought many serious challenges to the clinical workplace, and was a catalyst to novel approaches to the way in which we practice medicine. These challenges include extreme...
6.
Trapnell B, Inoue Y, Bonella F, Morgan C, Jouneau S, Bendstrup E, et al.
N Engl J Med
. 2020 Sep;
383(17):1635-1644.
PMID: 32897035
Background: Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disease characterized by progressive surfactant accumulation and hypoxemia. It is caused by disruption of granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling, which pulmonary...
7.
Patel B, Arachchillage D, Ridge C, Bianchi P, Doyle J, Garfield B, et al.
Am J Respir Crit Care Med
. 2020 Jul;
202(5):690-699.
PMID: 32667207
Clinical and epidemiologic data in coronavirus disease (COVID-19) have accrued rapidly since the outbreak, but few address the underlying pathophysiology. To ascertain the physiologic, hematologic, and imaging basis of lung...
8.
Chua F, Armstrong-James D, Desai S, Barnett J, Kouranos V, Kon O, et al.
Lancet Respir Med
. 2020 Mar;
8(5):438-440.
PMID: 32220663
No abstract available.
9.
Trapnell B, Nakata K, Bonella F, Campo I, Griese M, Hamilton J, et al.
Nat Rev Dis Primers
. 2019 Mar;
5(1):16.
PMID: 30846703
Pulmonary alveolar proteinosis (PAP) is a syndrome characterized by the accumulation of alveolar surfactant and dysfunction of alveolar macrophages. PAP results in progressive dyspnoea of insidious onset, hypoxaemic respiratory failure,...
10.
Arachchillage D, Passariello M, Laffan M, Aw T, Owen L, Banya W, et al.
Semin Thromb Hemost
. 2018 Mar;
44(3):276-286.
PMID: 29566407
Intracranial hemorrhage (ICH) is a serious complication in patients receiving veno-venous extracorporeal membrane oxygenation (VV-ECMO) and is associated with high mortality. It is unknown whether ICH may be a consequence...